Pet Birds as Potential Reservoirs of Antimicrobial-Resistant Bacteria in Digestive and Respiratory Infections

Background/Objectives: Pet birds are increasingly recognized as potential reservoirs of zoonotic and antimicrobial-resistant bacteria, raising concerns within the One Health framework. However, data on bacterial diversity and resistance profiles in clinically affected ornamental birds remain limited. Methods: This study, conducted over three years (November 2022–March 2026), included 198 pet birds presenting with digestive and respiratory disorders. From these birds, clinical samples were analyzed bacteriologically; resulting isolates were identified by MALDI-TOF mass spectrometry, and antimicrobial susceptibility assessed using the Kirby-Bauer disk diffusion method according to EUCAST and CLSI guidelines. Results: Bacterial growth was detected in 87.9% of cases, yielding 249 distinct isolates. Gram-positive cocci predominated (62.3%), led by Staphylococcus spp. (33.3%) and Enterococcus spp. (9.6%), while Escherichia coli (9.2%) was the primary Gram-negative species. At the genus level, Staphylococcus spp. demonstrated high susceptibility to amikacin (88.5%) but significant resistance to gentamicin (75.6%) and oxytetracycline (63.6%). In contrast, Escherichia spp. isolates were largely resistant, showing only 50% susceptibility to enrofloxacin and 40% to doxycycline, with resistance to tylosin reaching 90%. Overall, 57% of isolates were multidrug-resistant, with Staphylococcus spp. contributing most to this burden. Conclusions: These findings characterize clinically ill pet birds as significant carriers of multidrug-resistant bacteria, highlighting the need for routine diagnostics and improved antimicrobial stewardship in avian medicine.